Literature DB >> 8674364

Hereditary susceptibility to colorectal cancer. Relatives of early onset cases are particularly at risk.

N R Hall1, D T Bishop, B M Stephenson, P J Finan.   

Abstract

Close relatives of patients with colorectal cancer are at an increased risk of developing a colorectal malignancy themselves. PURPOSE. A study was conducted to compare risks in relatives of patients diagnosed at different ages. METHODS. Family histories were taken from two cohorts of patients with colorectal cancer: Group A, a population group of 65 patients diagnosed at or under 45 (median, 42) years; Group B, 212 patients of all ages (median, 68 years) treated in a single surgeon's practice. RESULTS. Overall relative risk of colorectal cancer in first-degree relatives was 5.2 in Group A and 2.3 in Group B. There was familial clustering of colorectal cancers suggestive of hereditary nonpolyposis colorectal cancer in 13 (20 percent) families in Group A but in only 3 (1.5 percent) families in the second group. Cumulative incidence of colorectal cancer for relatives of the young cohort rose steeply from 40 years, reaching 5 percent at age 50 years and 10 percent at age 70 years. This contrasts with risk for relatives of older patients, in whom the shape of the curve resembles that of the overall population risk, reaching 5 percent at age 70 years and 10 percent at age 80 years. CONCLUSIONS. There appears to be a quantitative and qualitative increase in risk to relatives of patients diagnosed at a young age compared with those diagnosed later in life, at least part of which is likely to be the result of a hereditary susceptibility. Close relatives of early onset cases warrant more intensive endoscopic screening and at an earlier age than relatives of patients diagnosed at older ages.

Entities:  

Mesh:

Year:  1996        PMID: 8674364     DOI: 10.1007/bf02054437

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  6 in total

1.  Association between family history and mismatch repair in colorectal cancer.

Authors:  R P Coggins; L Cawkwell; S M Bell; G P Crockford; P Quirke; P J Finan; D T Bishop
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

Review 2.  A636P testing in Ashkenazi Jews.

Authors:  Jose G Guillem; Harvey G Moore; Crystal Palmer; Emily Glogowski; Rob Finch; Khedoudja Nafa; Arnold J Markowitz; Kenneth Offit; Nathan A Ellis
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

Review 3.  Is early-onset cancer an emerging global epidemic? Current evidence and future implications.

Authors:  Tomotaka Ugai; Naoko Sasamoto; Hwa-Young Lee; Mariko Ando; Mingyang Song; Rulla M Tamimi; Ichiro Kawachi; Peter T Campbell; Edward L Giovannucci; Elisabete Weiderpass; Timothy R Rebbeck; Shuji Ogino
Journal:  Nat Rev Clin Oncol       Date:  2022-09-06       Impact factor: 65.011

Review 4.  Colorectal carcinoma in the first decade of life: a systematic review.

Authors:  René Aloisio da Costa Vieira; Maiara Silva Tramonte; Luiz Fernando Lopes
Journal:  Int J Colorectal Dis       Date:  2015-04-28       Impact factor: 2.571

5.  Family history of colorectal cancer in a Sweden county.

Authors:  Louise Olsson; Annika Lindblom
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

6.  Can a print-based intervention increase screening for first degree relatives of people with colorectal cancer? A randomised controlled trial.

Authors:  Mariko Carey; Robert Sanson-Fisher; Finlay Macrae; Emilie Cameron; David Hill; Catherine D'Este; Jody Simmons; Christopher Doran
Journal:  Aust N Z J Public Health       Date:  2016-09-13       Impact factor: 2.939

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.